Deep Health AI India (DDIL): Company Update

Company Update Pursuant to Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, please find enclosed herewith the Statement of Deviation and variation for the Quarter and year ended March 31, 2026, and the detailed statement in relation to the same is enclosed as 'Annexure A'. Further, this is to inform you that the Rights Issue proceeds have been fully utilized during the quarter ended on March 31, 2026. Therefore, the filing of statement of de

1 min read Deep Health AI India

Company Update

Company Update

Pursuant to Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, please find enclosed herewith the Statement of Deviation and variation for the Quarter and year ended March 31, 2026, and the detailed statement in relation to the same is enclosed as 'Annexure A'. Further, this is to inform you that the Rights Issue proceeds have been fully utilized during the quarter ended on March 31, 2026. Therefore, the filing of statement of deviation(s) or variation(s) under the Regulation 32 SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 will not be applicable to the company from here onwards. A statement of deviation or variation for the Quarter and Year ended on March 31, 2026, is duly reviewed by the Audit Committee of the Company at its Meeting held today i.e. on May 29, 2026, and Utilisation Certificate issued by the Statutory Auditor, M/s VRSK & Co. LLP, Chartered Accountants. is enclosed herewith

Pursuant to Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, please find enclosed herewith the Statement of Deviation and variation for the Quarter and year ended March 31, 2026, and the detailed statement in relation to the same is enclosed as 'Annexure A'. Further, this is to inform you that the Rights Issue proceeds have been fully utilized during the quarter ended on March 31, 2026. Therefore, the filing of statement of deviation(s) or variation(s) under the Regulation 32 SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 will not be applicable to the company from here onwards. A statement of deviation or variation for the Quarter and Year ended on March 31, 2026, is duly reviewed by the Audit Committee of the Company at its Meeting held today i.e. on May 29, 2026, and Utilisation Certificate issued by the Statutory Auditor, M/s VRSK & Co. LLP, Chartered Accountants. is enclosed herewith

Disclaimer

This article is for informational purposes only and is not investment advice. Verify all figures and announcements from official exchange filings and company disclosures before making decisions.

#Deep Health AI India Ltd #DDIL #Corporate announcement
MARKET INTELLIGENCE

Track Indian stocks with ZTOX AI

NSE & BSE filings, quarterly results, insider trades, and smart volume alerts — delivered on WhatsApp or Telegram. No separate app to install.

Free
Essential tracking to get started
₹0
  • Track 5 companies
  • News, NSE/BSE & insider alerts
  • Daily FII/DII activity
POPULAR
Basic
For active investors
₹89/mo
  • Track 20 companies
  • Everything in Free
  • Results, volume & live gainer alerts
Advanced
Deeper market signals
₹119/mo
  • Track 50 companies
  • Everything in Basic
  • Block deals & 60-day volume breakouts

Need more? Pro tracks up to 500 companies with preferential issue alerts.

Start free

No credit card required. Connect WhatsApp or Telegram in minutes.